Chinese Science Group Accuses U.S. Anti-Aging Group Of Fraud
This article was originally published in PharmAsia News
A Chinese scientific group accused a U.S.-based non-profit group, American Academy of Anti-Aging Medicine, of swindling cancer patients by proffering an unapproved cancer treatment.
You may also be interested in...
Biologic Exclusivity Provisions In USMCA Are Boon To Generics Industry; BIO Is 'Tremendously Worried'
Revised North American trade deal touted as enabling Congress to address crisis of high drug prices; requirement for 10 years biologic exclusivity is removed and language to allow incentives for generics added.
The Gilead subsidiary presented updated data at ASH for its first CD19-targeting CAR-T Yescarta and pivotal results for KTE-X19, which it plans to submit for US FDA approval in mantle cell lymphoma this year.
Hiring travails, inspection pre-announcement, lack of translators highlighted in congressional hearing on FDA foreign inspections.